Zheng S, Verjans GMGM, Evers A, van den Wittenboer E, et al. CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation. Antiviral Res 2024;228:105950.
PMID: 38944159